Ada 2026: AstraZeneca advances oral GLP-1 elecoglipron into Phase III after positive trial data Scrip Pharma Intelligence 15h
Hong Kong's urban development near China border draws AstraZeneca, others Nikkei Asian Review 16h Article paywall
expert reaction to two studies looking at AstraZeneca’s GLP 1 pill, elecoglipron, for reducing weight and lowering blood-sugar in adults with and without type 2 diabetes Science Media Centre 15h
AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial Rock Hill Herald 16h Article paywall